News

Canadian scientists say these children may be at higher risk of Alzheimer's because they are more prone to one toxic protein, ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...
A dementia caregiver should be mindful of personality and behavior changes to best anticipate the patient’s needs. Find ...
In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.
People with special needs often have to drive hours to find a dentist who will see them. New grants are creating more options around California.
Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...
A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...
An extended study after a primary trial supports using the anti-amyloid drug lecanemab (Leqembi) for up to 36 months in ...
The play “Remembrance” just closed its off-B’way run. Subject? Caregiver for a parent with Alzheimer’s. Assessment: It’s ...
In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease.
University of South Carolina professor Dr. Shaun Owens is on a quest to tackle Alzheimer’s disease and related dementias.Dr. Owens is co ...